BioAge Labs logo

BioAge Labs, Inc.


BioAge Labs Stock

BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist that promoted muscle metabolism and prevented muscle atrophy on bed rest in a Phase 1b trial.

Management Team

Kristen Fortney Co-Founder, CEO
Eric Morgan Co-Founder, COO
Paul Rubin CMO, EVP of Research
Peng Leong CBO
Ann Neale CDO
Dav Goldstein CFO
BJ Sullivan Chief Strategy Officer

Funding Information